| Structure |
Chemical Name |
CAS |
MF |
 |
Axitinib Impurity 12 |
|
|
 |
Carfilzomib Impurity 3 |
|
|
 |
Palonosetron Impurity 22 |
1217547-14-2 |
C19H24N2O2 |
 |
Ticagrelor Impurity 39 |
|
|
 |
3-amino-6-chloro-2-methyl-4-phenylquinazolin-4-ol |
27537-87-7 |
C15H14ClN3O |
 |
(S)-methyl 2-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methylamino)-3-methylbutanoate |
1111177-24-2 |
C20H23N5O2 |
 |
BJQMFFOQQWEWAF-DGBYXFBUSA-N |
1709825-83-1 |
C31H41ClO8 |
 |
Cefminox Impurity C |
|
|
 |
Blonanserin impurity E |
|
|
 |
Decitabine Impurity 7 |
|
|
![2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol](/CAS/20150408/GIF/376608-75-2.gif) |
2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol |
376608-75-2 |
C17H24ClN5O4S |
 |
FEXOフェナジノン |
76811-98-8 |
C32H37NO4 |
 |
MFFANMLJBOSKIX-UHFFFAOYSA-N |
352457-34-2 |
C9H13N5O2 |
 |
Ceftriaxone IMpurity C |
|
|
![1-Piperazineethanol,4-[(2-chlorophenyl)(3-chlorophenyl)methyl]-, hydrochloride (1:2)](/CAS/20180808/GIF/126517-38-2.gif) |
1-Piperazineethanol,4-[(2-chlorophenyl)(3-chlorophenyl)methyl]-, hydrochloride (1:2) |
126517-38-2 |
C19H24Cl4N2O |
 |
Elagolix Impurity 40 |
|
|
 |
(S)-ethyl 3-((R)-5-oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylate(DD) |
|
|
 |
4-chloro-N-(3-chloro-4-fluorophenyl)-8-nitroquinazolin-7-amine |
|
|
 |
N2-Losartanyl-losartan (Losartan IMpurity) |
230971-72-9 |
C44H44Cl2N12O |
![2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)-](/CAS/20210305/GIF/2459302-85-1.gif) |
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
 |
Solifenacin Related Compound 18 |
1225338-27-1 |
C23H26N2O2 |
 |
N-(2-ベンゾイル-4-クロロフェニル)ホルムアミド |
10352-28-0 |
C14H10ClNO2 |
 |
Milnacipran Impurity 11 |
1410831-12-7 |
C11H10O2 |
![(7S)-3-(ヒドロキシメチル)-7-[[(2-チエニル)アセチル]アミノ]-7-メトキシセファム-3-エン-4-カルボン酸](/CAS/GIF/54333-94-7.gif) |
(7S)-3-(ヒドロキシメチル)-7-[[(2-チエニル)アセチル]アミノ]-7-メトキシセファム-3-エン-4-カルボン酸 |
54333-94-7 |
C15H16N2O6S2 |
 |
Dexmedetomidine-007 |
2240179-63-7 |
C13H16N2 |
![1,3-ビス[4-(2-メトキシエチル)フェノキシ]-2-プロパノール](/CAS/GIF/230975-30-1.gif) |
1,3-ビス[4-(2-メトキシエチル)フェノキシ]-2-プロパノール |
230975-30-1 |
C21H28O5 |
 |
6-amino-1,5-dimethylpyrimidine-2,4(1H,3H)-dione |
63959-47-7 |
C6H9N3O2 |
 |
Posaconazole iMpurity 6 |
2185472-85-7 |
C30H35N5O3 |
 |
Canagliflozin Impurity 58 |
|
|
 |
メトキシトリフェニルメタン |
596-31-6 |
C20H18O |
![3-Quinolinecarboxylic acid, 7-[(4aS,7aS)-1-acetyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-](/CAS/20210305/GIF/1395471-26-7.gif) |
3-Quinolinecarboxylic acid, 7-[(4aS,7aS)-1-acetyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo- |
1395471-26-7 |
C23H26FN3O5 |
 |
Afatinib Impurity 25 |
|
|
 |
EM-201 |
857839-61-3 |
C37H65NO12 |
 |
(R)-4-fluoro-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C23H24FN7O4 |
 |
Ozagrel Impurity B |
|
|
 |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-, acetate (9CI) |
402508-35-4 |
C11H18O6 |
![1,4,8,11-Tetraazacy clotetradecance, 1,4,8-tris[(4 Methylphenyl)sufonyl]-](/CAS/20150408/GIF/104395-69-9.gif) |
1,4,8,11-Tetraazacy clotetradecance, 1,4,8-tris[(4 Methylphenyl)sufonyl]- |
104395-69-9 |
C31H42N4O6S3 |
 |
Sugammadex sodium Org226100-1 Impurity |
|
|
 |
(11β,16β)-9-BroMo-11-hydroxy-16-Methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione |
52092-14-5 |
C28H37BrO7 |
 |
セテアリルグルコシド |
|
|
 |
ペリンドプリルジケトピペラジン |
129970-98-5 |
C19H30N2O4 |
 |
(S)-methyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
1911578-88-5 |
C16H13F5NO5P |
 |
Levosimendan Impurity 1 |
1643439-59-1 |
C22H23N7O2 |
 |
Ampicillin Impurity C |
|
|
 |
Mirabegron Impurity 3 |
|
|
 |
Bisoprolol EP Impurity N |
1346601-75-9 |
C17H29NO4 |
 |
D-erythro-Hexonic acid, 6-S-2-benzothiazolyl-2,4-dideoxy-6-thio-, 1,1-dimethylethyl ester |
1469771-46-7 |
C17H23NO4S2 |
 |
Peramivir Impurity 19 |
|
|
 |
Ceftiofur USP Impurity I |
|
|
 |
Linagliptin Impurity CD10088 |
|
|
 |
Ibubinib impurity |
|
|
 |
sofosBuvir Impurity 33 |
|
|
![[2-(4-Methoxyphenyl)-1-methylethyl]-formamide](/CAS/20180601/GIF/126002-14-0.gif) |
[2-(4-Methoxyphenyl)-1-methylethyl]-formamide |
126002-14-0 |
C11H15NO2 |
 |
Aprepitant Impurity 16 |
850354-60-8 |
|
 |
Brexpiprazole Impurity 15 |
|
|
 |
Mupirocin EP Impurity E |
71087-96-2 |
C26H44O9 |
 |
Montelukast Cyclopropaneacetonitrile |
866923-62-8 |
C35H35ClN2OS |
![4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid](/CAS/20211123/GIF/2469039-29-8.gif) |
4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid |
2469039-29-8 |
C16H21Cl2N3O2S |
 |
2’-Deschloro-2’-hydroxy Dasatinib |
1159977-25-9 |
C22H27N7O3S |
 |
3-ヒドロキシチオベンズアミド |
104317-54-6 |
C7H7NOS |
 |
Erlotinib Hydrochloride iMpurity 51 |
|
|
 |
(S)-ethyl 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetate |
870695-39-9 |
C8H13NO4 |
 |
4,5-ジブロモピロカテコール |
2563-26-0 |
C6H4Br2O2 |
 |
Troxipide Impurity 8 |
|
|
 |
Nintedanib Impurity A (Intedanib Impurity A ) |
|
|
 |
ACICLOVIR, Impurity J |
|
|
 |
PraMipexole IMpurity V (PraMipexole IMpurity Z) |
|
|
 |
4-(2-nitrophenyl)Morpholin-3-one |
845729-41-1 |
C10H10N2O4 |
 |
Didesmethyl Zolmitriptan |
139264-15-6 |
C14H17N3O2 |
 |
Oxacillin Impurity E |
|
|
 |
Ropivacaine impurity |
1105704-96-8 |
C12H14N2O3 |
 |
AztreonaM IMpurity D |
|
|
![[4-[3-(イソプロピルアミノ)-2-ヒドロキシプロピルオキシ]フェニル]メタノール](/CAS/GIF/62572-93-4.gif) |
[4-[3-(イソプロピルアミノ)-2-ヒドロキシプロピルオキシ]フェニル]メタノール |
62572-93-4 |
C13H21NO3 |
 |
Loratadine IMpurity E |
|
C22H23ClN2O2 |
![(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide](/CAS/20180703/GIF/CB93049205.gif) |
(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide |
|
C24H30ClN7O5S |
 |
Irsogladine Impurity DQJ |
61382-84-1 |
C9H6Cl2N4O |
 |
Irinotecan Impurity L |
|
|
 |
Vortioxetine Impurity 1 |
1293489-71-0 |
C17H20N2S |
 |
Ozagrel Impurity 10 |
|
|
 |
1-(((2R,4R)-4-((Benzyloxy)methyl)-2-(2,4-difluorophenyl)tetrahydrofuran-2-yl)methyl)-1H-1,2,4-triazole |
165115-83-3 |
C21H21F2N3O2 |
 |
Dapoxetine impurity 53 |
|
|
 |
Pregabalin Impurity 16 |
|
|
 |
tetrahydrofuran-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate |
1404453-75-3 |
C17H22O4 |
![(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル](/CAS/GIF/171596-44-4.gif) |
(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル |
171596-44-4 |
C20H18N2O4 |
 |
Cefradine Impurity F |
|
|
![1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide](/CAS/20150408/GIF/CB02681131.gif) |
1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide |
2098457-92-0 |
C26H27N5O4 |
 |
2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5S)- |
2514942-86-8 |
C13H15NO4 |
 |
Crisaborole Impurity 2 |
|
|
 |
AFTMPFJWAIDLME-QWHCGFSZSA-N |
1808087-53-7 |
C15H19N3O3S |
![α,α'-Bis[(2-Methoxyphenoxy)Methyl]-1,4-piperazinediethanol](/CAS/GIF/333749-57-8.gif) |
α,α'-Bis[(2-Methoxyphenoxy)Methyl]-1,4-piperazinediethanol |
333749-57-8 |
C24H34N2O6 |
 |
2H-3-Benzazepin-2-one, 3-(3-bromopropyl)-1,3,4,5-tetrahydro-7,8-dimethoxy- |
1192174-72-3 |
C15H20BrNO3 |
 |
Posaconazole iMpurity 4 |
2125944-53-6 |
C30H35N5O3 |
 |
Aureomycin Impurity K(EP) |
81163-11-3 |
C22H21ClN2O7 |
 |
Benzene,1-ethoxy-4-(phenylmethyl)- |
35672-52-7 |
C15H16O |
![(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylacetate](/) |
(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylacetate |
|
|
 |
Palbociclib Impurity 65 |
|
|
 |
sofosBuvir impurity 47 |
|
|
 |
Lumateperone Impurity 5 |
|
|
 |
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-, (αS,3aR,4R,6R,7aS)-, 2,2,2-trifluoroacetate (1:1) |
2363753-29-9 |
C17H29BF3NO4 |
 |
Atorvastatin Cyclic Isopropyl Impurity |
873950-17-5 |
C33H35FN2O7 |